Patent · US Active

Lactams as CBL-B inhibitors selective over C-CBL

US12187709B2 · kind B2 · utility

0Cited by
3References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 4, 2022
Grant dateJan 7, 2025
Priority date—
Expiry dateNov 4, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D493/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound, of formula (I): suitable for treating a cancer wherein the cancer is susceptible to inhibition of Cbl-B.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.